Furthermore, the anti-tumor effects of HSP60/E6 DNA and PE(ΔIII)/E6 fusion protein vaccines were weaker than those of the HSP60/E7 DNA and PE(ΔIII)/E7 fusion protein vaccines. The gene discussed is HSPD1; the disease is neoplasm.